Sanguine BioSciences

BiotechnologySeedWoburn, USsanguinebio.com

Latest round

Seed

Last raised

Feb 2013

Total raised

Undisclosed

Investors

2

About Sanguine BioSciences

Based in the US, Sanguine BioSciences, Inc.Sanguine BioSciences, Inc. operates in the biotechnology sector, focusing on biospecimen collection.00 mn from Catalio Capital Management on October 31, 2023.53 mn.Sanguine BioSciences specializes in the collection and distribution of biospecimens, including peripheral blood mononuclear cells (PBMCs), leukopaks, serum, plasma, and whole blood, sourced from a diverse donor population. The company uses a direct-to-donor model enabling individuals to participate in research while meeting researchers' sample requirements across immunology, oncology, and rare diseases.Sanguine BioSciences generates revenue through direct sales of biospecimen products and services, partnered with research institutions, pharmaceutical companies, and biotech firms. Their transactions often involve customized biospecimen collections tailored to specific research needs.In October 2023, Sanguine BioSciences, Inc. While specific new products are not detailed, the focus will include potential developments in their biospecimen offerings and a strategy for entering new geographic regions to enhance their market presence.

Who invested in Sanguine BioSciences

2 investors across 1 round

See all investors in Sanguine BioSciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Feb 21, 2013

    Amount

    Undisclosed

    Investors

    Locked

Questions about Sanguine BioSciences

Who invested in Sanguine BioSciences?

Sanguine BioSciences has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Sanguine BioSciences raised?

Sanguine BioSciences has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Sanguine BioSciences last raise money?

Sanguine BioSciences's most recent round on record is a Seed, in Feb 2013.

What does Sanguine BioSciences do?

Based in the US, Sanguine BioSciences, Inc.

Where is Sanguine BioSciences headquartered?

Sanguine BioSciences is headquartered in Woburn, US.

Which VCs invest in companies like Sanguine BioSciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sanguine BioSciences's stage. Their profiles are linked below.

Raising like Sanguine BioSciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.